Servier laying off 610 workers; China looks inward for biopharma growth;

@FierceBiotech: Star fund manager Woodford calls in ex-FBI agent to probe Northwest Bio allegations. Report | Follow @FierceBiotech

@JohnCFierce: Bristol-Myers gets elotuzumab OK for multiple myeloma -- Believe that makes 39 for the year so far. More | Follow @JohnCFierce

@DamianFierce: Actually, inversions are ... good? More from the NYT | Follow @DamianFierce

> Servier is plotting major staffing cuts in its native France, looking to lay off 610 workers in response to sluggish sales. News

> China is ramping up its efforts to grow a local biopharma industry, reforming its regulatory structure to encourage in-country companies to compete with multinationals. More

> Merck KGaA plans to launch a new drug every year from 2017 forward, incoming CEO Stefan Oschmann said, starting with a Pfizer ($PFE)-partnered cancer immunotherapy. Story

Medical Device News

@FierceMedDev: ICYMI: Scientists make strides with real-time estrogen sensor. Article | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Entellus wins FDA clearance for its endoscope to treat blocked sinus passages. Story | Follow @VarunSaxena2

@EmilyWFierce: JAMA: Valeant's 18-fold price hikes top widespread increases in dermatology prices. FiercePharma story | Follow @EmilyWFierce

> Wright Medical slapped with $11M verdict in bellwether case over metal hip implant. More

> Novartis' Alcon recalling more intraocular lenses due to reports of postoperative inflammation. Article

Pharma News

@FiercePharma: Report: Sanofi cooking up $12.7B animal health spinoff. FierceAnimalHealth story | Follow @FiercePharma

@EricPFierce: ICYMIFDA warning letter says Dr Reddy's hid existence of QC testing lab where retesting was done. Article | Follow @EricPFierce

@CarlyHFierce: ICYMI: Trump, Clinton lash out at Pfizer over Allergan deal. Article | Follow @CarlyHFierce

> Servier plots major layoffs in France after R&D setbacks, payer cuts. Story

> JAMA: Valeant's 18-fold price hikes top widespread increases in dermatology prices. More

> GSK's anticorruption overhaul in China may be hobbling sales. Article

Pharma Marketing News

> What caught our readers' fancy this year? Here's your top 10 FiercePharmaMarketing capsule. Editor's corner

> Amgen slaps $178K price on rare new leukemia drug Blincyto. More

> Top cancer doc takes to social media to fight rising prices. More

> Are Glaxo's China sales reforms putting it at a commercial disadvantage? More

> Big Pharma's bad rap made late-night TV, even before the Shkreli effect. More

Animal Health News

> Scientists roll out innovative health-tracking device for guide dogs. Report

> Report: Sanofi cooking up $12.7B animal health spinoff. Story

> Merck and Zoetis line up rival vaccines to fight new strain of dog flu. More

> Nexvet focuses first investor symposium on prospects for biotech in vet medicine. Article

> Petco abandons IPO plan in favor of $4.6B buyout. Item

Biotech IT News

> U.K. commits a further $375M to 100,000 Genomes Project. News

> Pfizer-Allergan merger raises questions about future of NuMedii deal. Item

> MediSapiens applies bioinformatics to find ideal leukemia treatment regimens. Report

> With PhIII trial coming up, Infinity strikes risk-based monitoring deal with Medidata. Story

> BGI slams brakes on Revolocity rollout, lays off staff in business rethink. Article